Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04878003
Title Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naive Myelofibrosis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kartos Therapeutics, Inc.
Indications

myelofibrosis

Therapies

TL-895

KRT-232

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.